Wilms Tumor in Children with AMER1/WTX Germline Pathogenic Variants: A Multicenter Case Series. Pediatr Blood Cancer. 2025 May 21; e31798. View Wilms Tumor in Children with AMER1/WTX Germline Pathogenic Variants: A Multicenter Case Series. Abstract

Update on Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin Cancer Res. 2025 May 15; 31(10):1831-1840. View Update on Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Abstract

Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries. Cancer. 2025 May 01; 131(9):e35862. View Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries. Abstract

Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children. Clin Cancer Res. 2025 May 01; 31(9):1573-1579. View Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children. Abstract

Prevalence, Characteristics, and Management of Pancreatic Tumors Among Children With Tuberous Sclerosis Complex. J Pediatr Surg. 2025 Apr 24; 60(7):162339. View Prevalence, Characteristics, and Management of Pancreatic Tumors Among Children With Tuberous Sclerosis Complex. Abstract

Prognostic Significance of Germline DICER1 Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell Tumor. JCO Precis Oncol. 2025 Apr; 9:e2400902. View Prognostic Significance of Germline DICER1 Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell Tumor. Abstract

Update on Surveillance in Von Hippel-Lindau Disease. Clin Cancer Res. 2025 Apr 15. View Update on Surveillance in Von Hippel-Lindau Disease. Abstract

Author Correction: Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency. Nat Commun. 2025 Mar 24; 16(1):2870. View Author Correction: Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency. Abstract

Case Series of Patients With FGFR1-Related Pheochromocytoma and Paraganglioma With a Focus on Biochemical, Imaging Signatures and Treatment Options. Clin Endocrinol (Oxf). 2025 Jun; 102(6):626-634. View Case Series of Patients With FGFR1-Related Pheochromocytoma and Paraganglioma With a Focus on Biochemical, Imaging Signatures and Treatment Options. Abstract

Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency. Nat Commun. 2025 Feb 28; 16(1):2049. View Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency. Abstract

Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex. Clin Cancer Res. 2025 Jan 17; 31(2):234-244. View Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex. Abstract

DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res. 2024 Dec 16; 30(24):5681-5692. View DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance Strategies. Abstract

Managing CDH1 Cancer Risks in a Child: Complex Decision Making in a Family With Hereditary Diffuse Gastric Cancer. Am J Med Genet A. 2025 Feb; 197(2):e63897. View Managing CDH1 Cancer Risks in a Child: Complex Decision Making in a Family With Hereditary Diffuse Gastric Cancer. Abstract

Strategies for Academic Advisors and Mentors to Support Medical Students Entering Clinical Rotations. Med Sci Educ. 2024 Dec; 34(6):1541-1550. View Strategies for Academic Advisors and Mentors to Support Medical Students Entering Clinical Rotations. Abstract

Neuroblastoma Predisposition and Surveillance-An Update from the 2023 AACR Childhood Cancer Predisposition Workshop. Clin Cancer Res. 2024 Aug 01; 30(15):3137-3143. View Neuroblastoma Predisposition and Surveillance-An Update from the 2023 AACR Childhood Cancer Predisposition Workshop. Abstract

Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors. Clin Cancer Res. 2024 Jun 03; 30(11):2342-2350. View Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors. Abstract

Anaplastic sarcoma of the kidney (DICER1-sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/DICER1 Registry. Pediatr Blood Cancer. 2024 Aug; 71(8):e31090. View Anaplastic sarcoma of the kidney (DICER1-sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/DICER1 Registry. Abstract

Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries. Gynecol Oncol. 2024 07; 186:117-125. View Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries. Abstract

Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition. NPJ Precis Oncol. 2024 Mar 11; 8(1):69. View Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition. Abstract

Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors. Pediatr Blood Cancer. 2023 11; 70(11):e30643. View Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors. Abstract

Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective. EJC Paediatr Oncol. 2023 Dec; 2. View Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective. Abstract

A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors. Cancer Med. 2023 06; 12(12):13300-13308. View A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors. Abstract

Perspectives of Rare Disease Experts on Newborn Genome Sequencing. JAMA Netw Open. 2023 05 01; 6(5):e2312231. View Perspectives of Rare Disease Experts on Newborn Genome Sequencing. Abstract

Genomic analysis reveals germline and somatic PDGFRB variants with clinical implications in familial infantile myofibromatosis. Pediatr Blood Cancer. 2023 06; 70(6):e30262. View Genomic analysis reveals germline and somatic PDGFRB variants with clinical implications in familial infantile myofibromatosis. Abstract

Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry. Cancer. 2023 02 15; 129(4):600-613. View Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry. Abstract

Learning About Mismatch Repair From a Rare Cancer Syndrome: A LOGICal Step Forward. J Clin Oncol. 2023 02 01; 41(4):727-731. View Learning About Mismatch Repair From a Rare Cancer Syndrome: A LOGICal Step Forward. Abstract

Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition. Cancer Prev Res (Phila). 2022 10 04; 15(10):645-652. View Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition. Abstract

Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/DICER1 Registry. J Clin Oncol. 2023 02 01; 41(4):778-789. View Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/DICER1 Registry. Abstract

Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nat Med. 2022 08; 28(8):1581-1589. View Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Abstract

Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. Am J Hum Genet. 2022 06 02; 109(6):1026-1037. View Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. Abstract

68 Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma. Pediatr Blood Cancer. 2022 08; 69(8):e29740. View 68 Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma. Abstract

DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis. J Neurooncol. 2022 May; 157(3):499-510. View DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis. Abstract

Thyroid Nodules in Children With Familial Adenomatous Polyposis. Am J Gastroenterol. 2022 07 01; 117(7):1166-1168. View Thyroid Nodules in Children With Familial Adenomatous Polyposis. Abstract

Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition. Cancer Med. 2022 04; 11(8):1745-1752. View Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition. Abstract

Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor. JCO Precis Oncol. 2021; 5. View Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor. Abstract

Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA Oncol. 2021 Dec 01; 7(12):1806-1814. View Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. Abstract

Belzutifan, a Potent HIF2a Inhibitor, in the Pacak-Zhuang Syndrome. N Engl J Med. 2021 11 25; 385(22):2059-2065. View Belzutifan, a Potent HIF2a Inhibitor, in the Pacak-Zhuang Syndrome. Abstract

Different Fumarate Hydratase Gene Variants Are Associated With Distinct Cancer Phenotypes. JCO Precis Oncol. 2021 11; 5:1568-1578. View Different Fumarate Hydratase Gene Variants Are Associated With Distinct Cancer Phenotypes. Abstract

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance. J Clin Oncol. 2021 09 01; 39(25):2779-2790. View Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance. Abstract

Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome. J Clin Endocrinol Metab. 2021 03 08; 106(3):e1121-e1130. View Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome. Abstract

DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor. Mod Pathol. 2020 10; 33(10):1910-1921. View DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor. Abstract

DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies-Response. Clin Cancer Res. 2019 03 01; 25(5):1689-1690. View DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies-Response. Abstract

It's ALL in the Family: IKZF1 and Hereditary Leukemia. Cancer Cell. 2018 05 14; 33(5):798-800. View It's ALL in the Family: IKZF1 and Hereditary Leukemia. Abstract

DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res. 2018 05 15; 24(10):2251-2261. View DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Abstract

Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study. Pediatr Blood Cancer. 2018 Feb; 65(2). View Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study. Abstract

Retinoblastoma and Neuroblastoma Predisposition and Surveillance. Clin Cancer Res. 2017 07 01; 23(13):e98-e106. View Retinoblastoma and Neuroblastoma Predisposition and Surveillance. Abstract

Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin Cancer Res. 2017 07 01; 23(13):e123-e132. View Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Abstract

Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome. Clin Cancer Res. 2017 Jun 15; 23(12):e62-e67. View Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome. Abstract

Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin Cancer Res. 2017 Jun 15; 23(12):e68-e75. View Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Abstract

PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin Cancer Res. 2017 Jun 15; 23(12):e76-e82. View PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Abstract

Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan. Pediatr Blood Cancer. 2017 05; 64(5). View Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan. Abstract

Socioeconomic status and global variations in the incidence of neuroblastoma: call for support of population-based cancer registries in low-middle-income countries. Pediatr Blood Cancer. 2017 02; 64(2):321-323. View Socioeconomic status and global variations in the incidence of neuroblastoma: call for support of population-based cancer registries in low-middle-income countries. Abstract

Parental hope for children with advanced cancer. Pediatrics. 2015 May; 135(5):868-74. View Parental hope for children with advanced cancer. Abstract

Use of a fever fast track tool to reduce time to antibiotic dose in febrile pediatric oncology patients. J Clin Oncol. 2014 Oct 20; 32(30_suppl):222. View Use of a fever fast track tool to reduce time to antibiotic dose in febrile pediatric oncology patients. Abstract

Neuromyelitis optica in an adolescent after bone marrow transplantation. Pediatr Neurol. 2015 Jan; 52(1):119-24. View Neuromyelitis optica in an adolescent after bone marrow transplantation. Abstract

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Hum Mutat. 2014 Jun; 35(6):654-62. View Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Abstract

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4605-10. View Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Abstract

Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain. J Cell Biol. 2001 Mar 19; 152(6):1233-46. View Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain. Abstract